Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
Stephanie L. Harrison, Benjamin J. R. Buckley, Deirdre A. Lane, Paula Underhill, Gregory Y.H. Lip
Topics & Concepts
Coronavirus disease 2019 (COVID-19)DementiaAntipsychoticMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PsychiatrySchizophrenia (object-oriented programming)Internal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts